CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-15 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −120 | $989.14 | $119K | 836,383 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −7,864 | $979.05 | $7.7M | 400,336 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −295 | $980.64 | $289K | 400,041 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −1,081 | $981.50 | $1.1M | 398,960 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −235 | $982.66 | $231K | 398,725 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −250 | $983.91 | $246K | 398,475 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −305 | $984.00 | $300K | 398,170 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −281 | $985.72 | $277K | 397,889 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −103 | $986.57 | $102K | 397,786 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −228 | $987.46 | $225K | 397,558 |
| 2024-05-15 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −299 | $988.76 | $296K | 397,259 |
| 2024-05-14 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −22,698 | $979.16 | $22.2M | 410,502 |
| 2024-05-14 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −2,302 | $980.10 | $2.3M | 408,200 |
| 2024-05-13 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Option exercise 10b5-1 | +203,204 | $399.66 | $81.2M | 577,633 |
| 2024-05-13 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Shares withheld for taxes 10b5-1 | −144,433 | $976.79 | $141.1M | 433,200 |
| 2024-05-13 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −203,204 | 0 | ||
| 2024-05-03 | SING GEORGE L Director | Option exercise | +2,000 | $413.33 | $827K | 28,349 |
| 2024-05-03 | SING GEORGE L Director | Shares withheld for taxes | −877 | $942.53 | $827K | 27,472 |
| 2024-05-03 | SING GEORGE L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,000 | 3,338 | ||
| 2024-05-01 | McCourt Marion EVP Commercial | Sale 10b5-1 | −250 | $889.41 | $222K | 12,931 |
Page 29 of 49 · 971 trades